Gordon Watt

Group leader

In 2024, Gordon (Gordie) Watt began work as a Junior Group Leader at NKI. His group is focused on prediction and early detection of cancer late effects using genetics and imaging markers.

Read more about our group.

Genetic epidemiology

Breast imaging

Late effects

Cancer epidemiologist Gordon (Gordie) Watt joined the Netherlands Cancer Institute on July 1 as our new group leader. With his extensive background in cancer research, especially in imaging and survivorship, Gordie brings valuable insights and expertise to the institute, primarily in terms of improving the lives of cancer survivors. We had the opportunity to speak with him in his new office at the Netherlands Cancer Institute.

Read the interview here.

Work experience

2021-2024: Instructor, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center (New York, NY, USA)

2018-2021: Postdoctoral research fellow, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center (New York, NY, USA)

2014-2018: PhD in Epidemiology, UTHealth Science Center at Houston School of Public Health, Brownsville Regional Campus (Brownsville, Texas, USA)
Dissertation: “Clinical and genetic characteristics of liver disease among Mexican Americans in south Texas”

2015-2018: Predoctoral research fellow, Department of Health Promotion and Behavioral Sciences, UTHealth Science Center at Houston, (Houston, Texas, USA)

2017: Summer Research Program Fellow, Department of Molecular and Cellular Oncology, M.D. Anderson Cancer Center (Houston, Texas, USA)

2010-2014: BA with Honors, University of Texas at Austin (Austin, TX, USA)

Gordon Watt

Group leader

This site uses cookies